Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors
Clinical trial NCT06771622 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06771622
- Sponsor
- FBD Biologics Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-13
- Primary completion
- 2028-01-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.